Scientists probe Life-Saving antibiotic mystery in critically ill
NCT ID NCT07167524
Summary
This study aims to understand how kidney dialysis machines filter a common antibiotic (piperacillin-tazobactam) out of the blood of intensive care patients with severe infections. Researchers will measure drug levels in 24 ICU patients who are on dialysis and receiving this antibiotic. The goal is to gather data to help doctors prescribe the most effective and safe dose for these critically ill patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Rouen Hospital
Rouen, 76031, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.